Anderson Darby reported option exercise involving 6,740 derivative units of Addus HomeCare Corp at $0.00 for $0 on Nov 10, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
EVP, Chief Govt Rel Officer
EVP, Chief Govt Rel Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
6,740Employee Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 10, 2026Option exercise
Filed
Nov 12, 2026, 4:30 PM ET2-day reporting delay
Accession
0001437749-26-036594Code M · Transaction 399093
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Sell4,220$122.30−$516,106Trade 399091
Nov 10, 2026Sell2,520$123.41−$310,993.20Trade 399092
Nov 10, 2026Option exercise6,740$34.05$229,497Trade 399090
4 transaction rows in this filing. Joint filers share the same rows.

ADUS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ADUS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −7.6%1w ago −1.2%1d ago −1.2%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.85 to $122.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.95 to $123.64, inclusive. F3: All options are fully vested.